Chemoinformaics analysis of 10-Bromostrictosidine
Molecular Weight | 609.47 | nRot | 7 |
Heavy Atom Molecular Weight | 576.206 | nRig | 29 |
Exact Molecular Weight | 608.137 | nRing | 5 |
Solubility: LogS | -2.31 | nHRing | 4 |
Solubility: LogP | 1.092 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 1 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 9 | No. of Arom Bond | 10 |
nHA | 10 | APOL | 79.5622 |
nHD | 6 | BPOL | 43.4378 |
QED | 0.198 |
Synth | 4.951 |
Natural Product Likeliness | 2.047 |
NR-PPAR-gamma | 0.008 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.169 |
HIA | 0.915 |
CACO-2 | -5.687 |
MDCK | 0.0000268 |
BBB | 0.661 |
PPB | 0.668885 |
VDSS | 0.764 |
FU | 0.55352 |
CYP1A2-inh | 0.023 |
CYP1A2-sub | 0.136 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.302 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.248 |
CYP2d6-inh | 0.03 |
CYP2d6-sub | 0.333 |
CYP3a4-inh | 0.275 |
CYP3a4-sub | 0.465 |
CL | 0.993 |
T12 | 0.227 |
hERG | 0.705 |
Ames | 0.397 |
ROA | 0.922 |
SkinSen | 0.033 |
Carcinogencity | 0.942 |
EI | 0.005 |
Respiratory | 0.955 |
NR-Aromatase | 0.013 |
Antiviral | Yes |
Prediction | 0.867854 |